Intravenous Immune Globulin (IVIG) Demonstration Update for a New Drug Code J1554 - ASCENIV
The purpose of this Change Request (CR) is to add a new J codes (J1554 - ASCENIV). The long description as listed in the Local Coverage Determination (LCD) is INJECTION, IMMUNE GLOBULIN (ASCENIV), 500 MG. and is to be included in the list of approved J codes for the treatment of Primary Immune Deficiency Diseases (PIDD) in the home for the IVIG Demonstration.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 21, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.